PUBLICATIONS 2013

Acute Cerebrovascular Disease in the Young: the Stroke in Young Fabry Patients (sifap) Study

Author: Arndt Rolfs, Hermann Mascher, several authors
Publisher: Stroke 2013, published online Jan. 10

PUBLICATIONS 2012

Lyso-globotriaosylsphingosine (lyso-Gb(3)) levels in neonates and adults with the Fabry disease later-onset GLA IVS4+919G>A mutation.

Author: Chien YH, Bodamer OA, Chiang SC, Mascher H, Hung C, Hwu WL.
Publisher: J Inherit Metab Dis., 2012, Oct.

Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene

Author: Jan Lukas, Joan Torras, Itziar Navarro, Anne-Katrin Giese, Tobias Böttcher, Hermann Mascher, Karl J. Lackner, Guenter Fauler, Eduard Paschke, Josep M. Cruzado, Ales Dudesek, Matthias Wittstock, Wolfgang Meyer and Arndt Rolfs
Publisher: Clinical Kidney Journal, 2012, 5, 395–400

Sensitive Determination of the Peptide AP301 - A Motif of TNF-α – from Human Plasma using HPLC-MS/MS.

Author: Daniel Mascher, Werner Tscherwenka, Bernhard Fischer, Hermann Mascher
Publisher: J Chromatogr. B, 2012, 908, 18-22

Dose Escalation Study in Healthy Male Subjects to Investigate Safety, Tolerability and Systemic Exposure of Orally Inhaled Single-Doses of AP301.

Author: H. Pietschmann, H. Fischer, S. Tzotzos, B. Fischer, M. Zeitlinger, R. Lucas, R. Hermann, Hermann Mascher, (Vienna, Austria, Augusta, USA).
Poster: European Respiratory Society - Annual Congress, 09/12, Vienna

Bioavailability and Disposition of Azelastine and Fluticasone Propionate when Delivered by MP29-02, a Novel Aqueous Nasal Spray.

Author: Hartmut Derendorf, Ullrich Munzel, Ursula Petzold, Joachim Maus, Hermann Mascher, Robert Hermann, Jean Bousquet
Publisher: Br J Clin Pharmacol, 2012, 74, 125-133

Lyso-GB3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease

Author: Markus Niemann, Arndt Rolfs, Anne Giese, Hermann Mascher, Frank Breunig, Georg Ertl, Christoph Wanner, Frank Weidemann
Publisher: Journal of Inherited Metabolic Disease Report, 2012, July

PUBLICATIONS 2011

Cracking Septic Brains: Regional (Dys)Functions Separate Survivors from non-Survivors

Author: K. Weixelbaumer, S. Drechsler, D. Mascher, P. Raeven, G.A. Feichtinger, H. Redl, S. Bahrami, M.F. Osuchowski
Publisher: SHOCK, 2011, Vol. 36, Supplement 1, ABS: 100

Morphological Alterations of the Cornea in the Mouse Model of Niemann-Pick Disease Type C1

Author: Marine Hovakimyan, Oliver Stachs, Maria Reichard, Jan Lukas, Moritz Johannes Frech, Rudolf Guthoff, Martin Witt, Hermann Mascher, Arndt Rolfs, Andreas Wree
Publisher: CORNEA, 2011, 30, 796-803

PUFAs, polyphenols, phosphatidylcholine and L-carnitine in combination reduces plasma lipid fractions and concomitantly affects gene expression profiles in blood mononuclear cells in hyperlipidemic subjects and in liver and muscle tissue of aged rats

Author: A. Lohninger, U. Radler, S. Lechner, G. Lienbacher, R. Krepp, E. Zeller, M. Brachinger, Ch. Anzur, D. Koffler, B. Fitz, D. Mascher, Ch. Anderwald, A. Strasser, C. Laschan, H. Stangl
Publisher: American J Clin Nutr, 2011, 58, 133-140

Frequency of Fabry disease in patients with small-fibre neuropathy of unknown aetiology: a pilot study

Author: C. Tanislav, M. Kaps, A. Rolfs, T. Böttcher, K. Lackner, E. Paschke, H. Mascher, M. Laue, F. Blaes
Publisher: Eur J Neurol, 2011, 18, 631-636
Abstract

PUBLICATIONS 2010

Exposure Patterns of UV Filters, Fragrances, Parabens, Phthalates, Organochlor Pesticides, PBDEs, and PCBs in Human Milk. Correlation of UV Filters with Use of Cosmetics

Author: Margret Schlumpf, Karin Kypke, Matthias Wittassek, Juergen Angerer, Hermann Mascher, Daniel Mascher, Cora Vökt, Monika Birchler, Walter Lichtensteiger
Publisher: Chemosphere 81 (2010) 1171-1183Abstract

pharm-analyt - Labor GmbH. - Your research - Our analytics - Your success